| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/10/2003 | US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects |
| 04/10/2003 | US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 04/10/2003 | US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders |
| 04/10/2003 | US20030069298 Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof |
| 04/10/2003 | US20030069297 4-aryl substituted indolinones |
| 04/10/2003 | US20030069291 3-heterocyclylpropanohydroxamic acid PCP inhibitors |
| 04/10/2003 | US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/10/2003 | US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 04/10/2003 | US20030069280 S(-)rabeprazole compositions and methods |
| 04/10/2003 | US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 04/10/2003 | US20030069248 Antiinflammatory agents; controlling cell cycle |
| 04/10/2003 | US20030069243 Novel substituted imidazole compounds |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/10/2003 | US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents |
| 04/10/2003 | US20030069228 Capase inhibitors; antiinflammatory agents |
| 04/10/2003 | US20030069217 Methods of prevention and treatment of ischemic damage |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 04/10/2003 | US20030069191 Pantethinesulphonic acid and/or a salt thereof as a free-radical scavenger |
| 04/10/2003 | US20030069175 A cyclic peptide, e.g., cyclic (Tyr-Gly-Phe-Gly-Gly) useful for stimulating the formation of osteoblastic or fibroblastic cells, enhancing bone formation, repairing fractures, healing wounds, grafting intraosseous implants, etc. |
| 04/10/2003 | US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
| 04/10/2003 | US20030068343 Phytosphingosine, an antioxidant, an antibacterial of at least hinokitiol and a salicylate, a polysaccharide and gorgornian extract for an anti-irittating effect on skin treated with a retinoid |
| 04/10/2003 | US20030068333 Cocktail of >/= 4 different plasmid DNAs encoding corresponding respiratory syncytial virus antigens, coacervated with chitosan to formulate nanospheres |
| 04/10/2003 | US20030068331 Dressing for treatment of a dermatological disease comprised of a gum resin, a topically acceptable volatile solvent, and a pharmacologically active agent |
| 04/10/2003 | CA2466020A1 Rsv gene expression vaccine |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2462599A1 Storage-stable fibrinogen solutions |
| 04/10/2003 | CA2462596A1 Storage-stable human fibrinogen solutions |
| 04/10/2003 | CA2462142A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 04/10/2003 | CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | CA2461928A1 Solvent extraction process |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2460909A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300153A1 Use of n-desulfated heparin for treating or preventing inflammations |
| 04/09/2003 | EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 04/09/2003 | EP1300138A2 Agents effective against hyperreactive and hypoactive deficient skin conditions as well as manifest dermatitis |
| 04/09/2003 | EP1299560A2 Identification and modulation of t helper-1 and t helper-2 cells |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299542A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299533A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |
| 04/09/2003 | EP1299430A2 Process for preparing benzoxazin-4-one polymer conjugates |
| 04/09/2003 | EP1299424A1 COLD WATER SOLUBLE $g(b)-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299415A1 Chemokine receptor modulators, production and use |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP1299374A1 Novel non-psychotropic cannabinoids |
| 04/09/2003 | EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 04/09/2003 | EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 04/09/2003 | EP1299363A1 Polymorphic forms/hydrates of n- 4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 04/09/2003 | EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 04/09/2003 | EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives |
| 04/09/2003 | EP1299157A1 Composition and applicator for topical substance delivery |
| 04/09/2003 | EP1299134A1 The use of honey in wound dressings |
| 04/09/2003 | EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 04/09/2003 | EP1299100A1 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist |
| 04/09/2003 | EP1299086A1 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 04/09/2003 | EP1299081A1 Use of oligosaccharides to stimulate beta-endorphin production |
| 04/09/2003 | EP1299068A1 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 04/09/2003 | EP1299059A1 Method and manufacture of a wound dressing for covering an open wound |
| 04/09/2003 | EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 04/09/2003 | EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 04/09/2003 | EP1218021B1 Apple tree branch extracts for dermato-cosmetic use and method for preparing same |
| 04/09/2003 | EP1140117B1 Aciclovir compositions containing dimethicone |
| 04/09/2003 | EP1001766B1 Compounds for the treatment of ccr5-mediated diseases |
| 04/09/2003 | EP0973531B1 Facilitation of wound healing with cm101/gbs toxin |
| 04/09/2003 | EP0963197A4 Guanylhydrazones useful for treating diseases associated with t cell activation |
| 04/09/2003 | EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists |
| 04/09/2003 | EP0881881B1 Antiparasitic composition for treating and protecting pets |
| 04/09/2003 | EP0862440B1 Therapeutic use of hemoglobin in promoting wound healing |
| 04/09/2003 | EP0848612B1 Use of calendula glycosides for the treatment of psoriasis |
| 04/09/2003 | EP0841895B1 Slimming cream based on plants |
| 04/09/2003 | EP0778774B1 New use of prostaglandins |
| 04/09/2003 | EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409715A Cyclopenteneone derivatives |
| 04/09/2003 | CN1409712A Pyrrolo [2,3-d] pyrimidine compounds |
| 04/09/2003 | CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 04/09/2003 | CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder |
| 04/09/2003 | CN1409637A Skin-care agent, skin antiaging agent, whitening agent and external skin preparations |
| 04/09/2003 | CN1409636A Use of honey in medical dressings |
| 04/09/2003 | CN1409630A Sustainable-release formulations for treating CNS-mediated disorders |
| 04/09/2003 | CN1409626A Catechol oximes and their use in cosmetic and dermatological preparations |
| 04/09/2003 | CN1408421A Traditional Chinese herbal medicine for curing frostbite |
| 04/09/2003 | CN1408409A Hair restorer |
| 04/09/2003 | CN1408406A Medicinal composition for curing skin disease |
| 04/09/2003 | CN1408403A Capsule for wind-expelling and white clearing |
| 04/09/2003 | CN1408398A Medicine for curing psoriasis and its preparing method |
| 04/09/2003 | CN1408395A Paste for curing burn and scald and its preparing method |
| 04/09/2003 | CN1408391A Paste for curing posriasis and its preparing method |
| 04/09/2003 | CN1408382A Medicine for curing bed sore and ulcer |
| 04/09/2003 | CN1408379A Notoginseng and pangolin scales tinea curing pill |
| 04/09/2003 | CN1408361A Quick-acting prickly-heat powder |